|
CN112263579A
|
|
Anti-tumor pharmaceutical composition and application thereof
|
|
CN111378026A
|
|
Method for preparing PEG (polyethylene glycol) biological molecules with controllable binding sites
|
|
CN110960685A
|
|
Polyethylene glycol-anesthetic drug conjugate compound
|
|
CN111995513A
|
|
Preparation method of 9-hydroxymethyl-fluorenic acid
|
|
CN109589415A
|
|
A kind of conjugate of polyethylene glycol-polypeptide and protein medicaments
|
|
CN108727208A
|
|
A kind of connexon compound, polyethylene glycol-connexon conjugate and its derivative and polyethylene glycol-connexon-drug conjugates
|
|
CN107789628A
|
|
A kind of application of conjugate of polyethylene glycol and local anesthetic in non-narcotic analgesia
|
|
CN108653280A
|
|
A kind of tablet and preparation method containing protein kinase G inhibitor
|
|
CN108658947A
|
|
Compound JK-03M or its pharmaceutically acceptable salt with higher protein kinase G inhibitory activity and preparation method thereof
|
|
CN106310289A
|
|
Conjugate of polyethylene glycol and narcotic and preparation method thereof
|
|
CN110448533A
|
|
A kind of pharmaceutical composition and preparation method thereof of polyethyleneglycol modified camptothecin derivative
|
|
CN105693520A
|
|
Compounds with higher PKG (protein kinase G) inhibitory activity and preparation method of compounds
|
